New 340B drug rule sets drugmaker fines Consumer health groups are praising Health and Human Services’ (HHS) new rule on the Medicaid 340B drug discount program, which sets a ceiling on drug prices. Helping Small Organizations Meet the 340B Challenge Many smaller organizations rely on the 340B program to continue serving their communities – and they can’t afford penalties for noncompliance. Four reasons why a hospital should open an integrated pharmacy September 25, 2016 By Dana Fox When is retail right? Consider these four benefits that will impact the bottom line. Explore three pathways to fast-growing pharmacy niche July 10, 2016 By Jill Sederstrom There are more ways than one to run a specialty pharmacy — and success can be found with any of them. Five top trends for health-system pharmacies in 2016 Value is not just about controlling costs; it also means increasing revenues. Health systems expect it, and pharmacy departments deliver. Top 10 Managed Healthcare Executive articles of 2015 December 17, 2015 By Aubrey Westgate What Managed Healthcare Executive content was most popular this year? Find out here. Judge rules: Orphan drugs not subject to 340B discounts October 16, 2015 By Tracey Walker Judge Rudolph Contreras ruled against the Department of Health and Human Services by saying that pharma companies do not have to offer rural and cancer hospitals that serve low-income populations 340B discounts on orphan drugs. 340B hospitals cost Medicare more than 50% more for cancer care September 17, 2015 By Tracey Walker A recent report evaluates the "true cost" of the 340B program. Read the key findings. Fighting back against 340B criticisms In this commentary, three pharmacy experts explain why they believe the 340B Drug Program is a needed safety net for safety net hospitals. 340B drug program causing controversy April 03, 2015 Controversy surrounds the 340B Drug Discount Program, and many industry leaders agree that the healthcare law plays a large part.